U.S. Markets closed

Silicon Laboratories shares defended at Williams Capital

Williams Capital said Silicon Laboratories weakness related to legacy business declines is a buying opportunity. The firm believes Siiicon's increased mix towards higher margin, longer-lived new products will drive gains and shares higher. The firm rates shares a Buy with a $52 price target.